Latest available resultsQuarter ended July 4, 202610-Q · August 11, 2026
Filed with the SECWATERS CORP /DE/
WATHealthcare
Next reportNovember 2, 2026pre-market · Analyst forecast 4.039 $/share
Revenue
$1.65B
▲ +113.4% vs prior year% YoY
Net income
−$136.00M
▼ -192.5% vs prior year% YoY
EPS
-1.39$
▼ -156.3% vs prior year% YoY
Net margin
-8.3%
▼ -27.3 percentage points vs prior year pp YoY
Revenue▲ +113.4 %
Margins (% of revenue)Gross N/AOperatingNet
Net income▼ -192.5 %
EPS▼ -156.3 %
View financial tableQuarter ended July 4, 2026
| Metric | Value | Context |
|---|---|---|
| Operations | ||
| Revenue | $1.65B | |
| Gross profit | — | |
| Operating income | −$86.00M | -5.2 % |
| Net income | −$136.00M | -8.3 % |
| R&D | $122.00M | 7.4 % |
| EPS (diluted) | -1.39 $ | |
| Balance sheet | ||
| Assets | $24.75B | |
| Liabilities | $9.56B | |
| Equity | $15.20B | |
| Cash | $539.00M | |
| Capital | ||
| Shares outstanding | 98.25M | as of 2026-08-07 |
| Public float | — | |